MACK
New
The question comes up all the time when we have a new patient starting on Rituxan.
The labs need to be drawn prior to therapy to check for hepatitis.
They have not started nor have been on therapy. The patients seem to have denials for
the hepatitis labs being drawn.. If anyone has any other ideas.
Here are the choices they are currently using:
V58.11 Encounter For Antineoplastic Chemotherapy
V58.12 Encounter For Immunotherapy For Neoplastic Condition
V67.51 Follow-up Examination, Following Completed Treatment With High-risk Medication, Not Elsewhere Classified
medication, not elsewhere classified
Excludes: long-term (current) drug use (V58.61-V58.69)
The labs need to be drawn prior to therapy to check for hepatitis.
They have not started nor have been on therapy. The patients seem to have denials for
the hepatitis labs being drawn.. If anyone has any other ideas.
Here are the choices they are currently using:
V58.11 Encounter For Antineoplastic Chemotherapy
V58.12 Encounter For Immunotherapy For Neoplastic Condition
V67.51 Follow-up Examination, Following Completed Treatment With High-risk Medication, Not Elsewhere Classified
medication, not elsewhere classified
Excludes: long-term (current) drug use (V58.61-V58.69)